Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs FBTAX overlap: 30% of top holdings shared

Bottom line

How much do IBB and FBTAX overlap?

30% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 39.5% of IBB's assets and 24.9% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

IBBFBTAX
Weight overlap (top 25)30%
Shared holdings9
Weight in shared holdings39.5%24.9%
Total positions254129
Expense ratio0.44%0.94%
Holdings as ofSep 30, 2025Jul 31, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Holdings IBB and FBTAX have in common

Holding% of IBB% of FBTAXOverlap
Vertex Pharmaceuticals, Inc.7.66%1.39%1.39%
Gilead Sciences, Inc.7.52%5.70%5.70%
Amgen, Inc.7.50%2.37%2.37%
Alnylam Pharmaceuticals, Inc.5.68%3.62%3.62%
Argenx SE3.15%3.00%3.00%
Insmed, Inc.2.95%3.05%2.95%
Natera, Inc.2.11%1.43%1.43%
Biogen, Inc.2.03%2.71%2.03%
Moderna, Inc.0.88%1.60%0.88%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. Regeneron Pharmaceuticals, Inc. — 5.70%
  3. IQVIA Holdings, Inc. — 3.18%
  4. Mettler-Toledo International, Inc. — 2.49%
  5. BeOne Medicines Ltd. — 2.11%
  6. United Therapeutics Corp. — 1.82%
  7. Waters Corp. — 1.77%
  8. Incyte Corp. — 1.62%
  9. Illumina, Inc. — 1.41%
  10. Genmab A/S — 1.38%
  11. Neurocrine Biosciences, Inc. — 1.34%
  12. Medpace Holdings, Inc. — 1.16%
  13. Exelixis, Inc. — 1.07%
  14. Ionis Pharmaceuticals, Inc. — 1.03%
  15. BioMarin Pharmaceutical, Inc. — 1.02%

Only in FBTAX

  1. Abbvie Inc — 14.71%
  2. Spyre Therapeutics Inc — 3.83%
  3. Dianthus Therapeutics Inc — 3.55%
  4. Cogent Biosciences Inc — 3.25%
  5. Oruka Therapeutics Inc — 3.24%
  6. Revolution Medicines Inc — 3.00%
  7. Ascendis Pharma A/s — 2.99%
  8. Mbx Biosciences Inc — 2.45%
  9. Amylyx Pharmaceuticals Inc — 2.25%
  10. Vaxcyte Inc — 1.97%
  11. Fidelity Revere Street Trust — 1.96%
  12. Relay Therapeutics Inc — 1.58%
  13. Viridian Therapeutics Inc — 1.53%
  14. Kiniksa Pharmaceuticals International Plc — 1.41%
  15. Enliven Therapeutics Inc — 1.25%

Asset mix

Asset typeIBBFBTAX
Stocks99.8%98.2%
Cash & short-term funds13.4%2.4%
Preferred stock—1.5%
Bonds—0.1%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Country mix

CountryIBBFBTAX
US98.6%87.8%
NL4.3%4.3%
DK2.2%3.0%
CH2.7%—
KY0.9%1.8%
GB1.0%1.8%
CA0.6%1.4%
BM0.7%1.2%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Check another pair

FAQ

How much do IBB and FBTAX overlap?
About 30% by weight. 9 securities appear in both funds' top 25 holdings; they make up 39.5% of IBB's assets and 24.9% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IBB and FBTAX have in common?
The largest shared holdings are Gilead Sciences, Inc., Alnylam Pharmaceuticals, Inc., Argenx SE, Insmed, Inc., Amgen, Inc..
Should I own both IBB and FBTAX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IBB or FBTAX?
IBB is broader, with 254 positions versus 129 for FBTAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.